NCT03349463 - Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 14, 2018

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions

Cervical CancerEndometrial CancerOvarian Epithelial Cancer

Interventions

DRUG

Fluciclovine F18

All study participants will receive 10 mCi of 18F-Fluciclovine (Axumin) one time administered through injection through the catheter into participant's arm immediately before PET/CT scan.

Trial Locations (1)

60153

RECRUITING

Loyola University Medical Center, Maywood